PERSPECTIVES AND SUMMARY 190 VITAMIN D3 HORMONE 191 Metabolism to the Active Form ......... . .... 191 Biologic Actions. ...... . ....... ......... . . . . . . ...... ..... ...... . . ... . . .. . . .... . . . . . ... 192 Transcriptional Mechanism of Action . . . . . . . . . . ....... . . . . .. . . . ...... . . 192 VITAMIN D3 RECEPTOR 193 Cellular Distribution. . 193 Biochemical Properties and Subcellular Distribution.. . .. . . . . . . . . . . . . . .. . . . . . . . . . . . . .... . . 194 Vitamin D3 Receptor Regulation.... . . . ........ . ..... . .... ........ . . . . .... .. . . . ...... 196 MOLECULAR BIOLOGY OF THE VITAMIN D3 RECEPTOR 198 Recombinant Cloning of the Vitamin D3 Receptor .... .... . ...... . . ..... .. . .. . ....... ...... 198 Steroid, Thyroid, and Retinoid Receptor Supeifamily 200 Structural Organization of the Nuclear Receptors ..... ....... . .. . . . .... . . . .. 200 Role of the Vitamin D3 Receptor in Transactivation . ........ . ...... . . . ..... . . ..... . . . . . .. 202 HUMAN SYNDROME OF HEREDITARY 1,25-DIHYDROXYVITAMIN D3 RESISTANCE 205 Vitamin DrResistant Fibroblast Model .... ......... . . ........ .. . . . . . . ...... 205 Genetic Lesions in the Vitamin D3 Receptor Chromosomal Locus . ....... . . ...... . . . .. 206 Functional Activity of Receptors Derived from Patient Genotypes 208 CONCLUSIONS 208
No takes yet. Share an insight, caveat, or question.
J. Wesley Pike (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: